
Our pick · Oct 2026
Embody
from $49/mo
Compounded semaglutide · 12-month plan · $588 up front · checked Oct 27
- LegitScript certified
Our pick is a commercial choice. We may earn a commission when you join.
Does DC Medicaid cover GLP-1s for weight loss?
If you are an adult and weight loss is your only reason, DC Medicaid does not cover a GLP-1.
If one of the uses below applies to you, your prescriber can ask DC Medicaid to cover that drug. Read the rule and its criteria.
Which drugs DC Medicaid covers, and for what:
We checked 2 official documents on October 15, 2026. This is information, not medical advice or a benefit decision.
4 programs that serve District of Columbia publish a complete monthly price, from $49 at Embody to $297 at Direct Meds GLP-1.

Our pick · Oct 2026
from $49/mo
Compounded semaglutide · 12-month plan · $588 up front · checked Oct 27
Our pick is a commercial choice. We may earn a commission when you join.
Some programs are affiliate partners, and we may earn a commission if you join through our link. Payment never moves a row. How we rank

Compounded semaglutide · 12-mo prepay
$588 up front
Advertised program price, not an insurance copay.
Good: 7.6/10 · Compounded
Checked Oct 16, 2026; a rating claim didn't match Trustpilot.
$588 upfront for 12 months of semaglutide. Yearly-plan sale ends December 1; confirm renewal. Paid terms are normally non-refundable; provider-determined medical disqualification allows a refund for the unused term, less services already provided.
The October 27–December 1, 2026 sale offers semaglutide at $49/month equivalent ($588 prepaid for twelve months) and tirzepatide at $99/month equivalent ($1,188 prepaid). One-month plans remain $79 and $129. The published terms say the rate stays fixed on the selected plan. Confirm the renewal amount and date before paying; these sale rates are not month-to-month bills.
We checked this price on Oct 27, 2026.
Full review and sources$99/mo equivalent at Trimi Health
12-mo prepay
$1,188 up front
Advertised program price, not an insurance copay.
Good: 7.6/10 · Compounded
Checked Jul 2, 2026.
$1,188 upfront for 12 months; applicable taxes may add to the bill 12-month prepay: $1,188 upfront ($99 monthly equivalent); does not auto-renew. The separate month-to-month semaglutide plan is $175
We checked this price on Oct 20, 2026.
Full review and sources$212/4 weeks equivalent at Enhance MD

48-week prepay
Advertised program price, not an insurance copay.
Excellent: 9.4/10 · Compounded
Checked Oct 16, 2026; some details not published.
Semaglutide 12-month plan rate, billed every 48 weeks. Shortest plan: $249 every 4 weeks. Confirm the upfront total and any discount.
$212 advertised four-week equivalent on the prepaid 48-week plan, not a calendar-year subscription; shortest plan is $249 billed every 4 weeks
We checked this price on Aug 28, 2026.
Full review and sourcesfrom$297/mo at Direct Meds GLP-1

Confirm the full bill
Advertised program price, not an insurance copay.
Good: 7.5/10 · Compounded
Checked Oct 16, 2026.
Confirm the current prescribed treatment and full bill with the provider.
We checked this price on Sep 3, 2026.
Full review and sources2 more programs serve District of Columbia without one complete monthly price: Maximus and Wellorithm. Compare their terms in the price index.
We left out 33 programs whose service-area list has a caveat for District of Columbia or is incomplete, so confirm your address at intake.
A program that serves District of Columbia still decides whether to prescribe. Before enrolling, confirm whether it accepts your Medicaid plan and whether your prescribed treatment is covered. The advertised cash prices are not insurance copays. Most listed programs sell compounded semaglutide or tirzepatide, which is not FDA-approved. Check a compounded provider before you pay.
Here is our summary of the DC Medicaid rules we checked, with their criteria and limits.
DC Medicaid covers GLP-1 medicines on its fee-for-service list only as diabetes drugs and excludes anti-obesity drugs, under its fee-for-service preferred drug list effective September 18, 2026. The list names anti-obesity drugs among its excluded classes and does not include Wegovy, Zepbound, Saxenda or Foundayo. DC Medicaid prefers Ozempic injection, Trulicity and liraglutide for diabetes, and it requires prior authorization for Mounjaro and Rybelsus. We did not find DC criteria for Wegovy heart-risk reduction or MASH, or for Zepbound sleep apnea, and we did not check each managed-care plan's formulary. If you are in a managed-care plan, ask it whether it covers your exact drug and diagnosis, and request the written criteria before you decide to pay cash.
A drug on the preferred list is not covered for every use, so check the rule for yours. A weight-loss exclusion leaves diabetes and other medical requests to their own rules.
We checked DC Medicaid fee-for-service preferred drug list, effective September 18, 2026 (excluded classes) on October 15, 2026.
We checked DC Medicaid preferred drug list page on October 15, 2026.
Call your Medicaid plan, Medicare drug plan or private insurer with these questions, and keep the reference number for each call.
Before you pay cash, confirm:
An “insurance accepted” badge does not tell you your benefit, so ask your plan how its review works.
Your prescriber sends DC Medicaid a request with the records that show you meet the rule for your drug and diagnosis, and DC Medicaid decides.
What your prescriber usually sends:
Your prescriber's office files the request; you cannot file it yourself. If DC Medicaid says no, ask for the reason in writing, because the notice tells you how to ask for a review and by when.
Medicare's GLP-1 Bridge follows federal rules in every state, so DC Medicaid's policy does not decide your Medicare benefit.
We checked CMS's Bridge guidance for Part D plans on September 26, 2026.
Two free official services can help you, and we earn no commission from either.
DC Medicaid covers GLP-1 medicines on its fee-for-service list only as diabetes drugs and excludes anti-obesity drugs, under its fee-for-service preferred drug list effective September 18, 2026.
The list names anti-obesity drugs among its excluded classes and does not include Wegovy, Zepbound, Saxenda or Foundayo. DC Medicaid prefers Ozempic injection, Trulicity and liraglutide for diabetes, and it requires prior authorization for Mounjaro and Rybelsus. We did not find DC criteria for Wegovy heart-risk reduction or MASH, or for Zepbound sleep apnea, and we did not check each managed-care plan's formulary. If you are in a managed-care plan, ask it whether it covers your exact drug and diagnosis, and request the written criteria before you decide to pay cash. Before you pay, confirm your exact drug, your diagnosis, any age rules and your plan's authorization steps.
Yes.
Medicare's GLP-1 Bridge follows federal eligibility rules in every state, not DC Medicaid's policy. Your ordinary Part D coverage depends on your prescription and your drug plan, and the Bridge runs its own eligibility and authorization review.
Yes, from 6 online programs that publish a service area including District of Columbia.
At intake, confirm your address, the exact medication and any pharmacy limits, because a state listing does not guarantee you a prescription or a delivery date.
Among programs that serve District of Columbia, the lowest complete monthly price we found is $49 at Embody.
Across the 10 compounded programs we track nationally, the median advertised recurring price is $124/mo, from $49 to $299. That national figure is not a measured District of Columbia average, insurance copay or quote for your dose.
Affiliate partners we feature. We may earn a commission.
Check the medication, commitment and total price for your selected plan.
Affiliate links, we earn a commission at no extra cost to you. These are featured partners, prioritized by our affiliate economics, not an editorial "best" ranking. Published scores have different evidence limits and do not establish better care. See the program comparison and scoring limitations.